Ostra Jewell was Appointed as Vice President Human Resources at G1 Therapeutics

Date of management change: September 10, 2019 

What Happened?

Research Triangle Park, NC-based G1 Therapeutics Appointed Ostra Jewell as Vice President Human Resources


About the Company

G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for the treatment of cancer. Two of the company`s pipeline assets, trilaciclib and G1T38, are CDK4/6 inhibitors, a validated and promising class of oncology therapeutics. Trilaciclib and G1T38 have broad therapeutic potential in many forms of cancer and may serve as backbone therapy of multiple combination regimens. Trilaciclib is a short-acting IV CDK4/6 inhibitor designed to preserve hematopoietic stem cell and immune system function (myelopreservation) during chemotherapy. G1T38 is a potential best-in-class oral CDK4/6 inhibitor for use in combination with other targeted therapies. G1 is also advancing G1T48, a potential best-in-class oral selective estrogen receptor degrader, or SERD, which is targeted for the treatment of ER+ breast cancer.


About the Person

Ostra Jewell is Vice President Human Resources at G1 Therapeutics. Previously, Ostra held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Farley Lee-Anne, Reid Canetta, Niffenegger Nichole, Messina Karen, Redfield Julie, Wilson David, Schroeder Sara, Speer Debbie, Morena Nora, Lopez Sarah, McElligott Maribeth

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.